Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Integumen Kicks Off Covid-19 Skin Trials

Wed, 03rd Jun 2020 11:52

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Wednesday and not separately reported by Alliance News:

----------

Integumen PLC - personal health care - Subsidiary Labskin to begin testing of anti-viral on cloned human skin coated in SARS-CoV-2 virus. Labskin investigation whether consumer and dental care products can reduce risk of spread of virus.

----------

Creo Medical Group PLC - medical devices - Initial data from Speedboat device shows it can save NHS hospitals in UK about GBP5,000 per surgical procedure. Some data found it saved one hospital more than GBP400,000. Creo Medical to report full data in October.

----------

Deltex Medical Group PLC - haemodynamic monitoring - Says pandemic means greater take up of TrueVue Doppler oesophageal monitoring system in intensive care units, especially in UK. But demand lower in standard operating rooms. Adds number of Covid-19 patients needing hospital treatment decreasing and some hospitals moving towards restarting elective surgeries. Deltex says too early to determine how much lost revenue in operating rooms can be recovered later in year.

----------

Novacyt SA - clinical diagnostics - To settle all outstanding obligations with lenders Harbert European Growth Capital and Vatel Capital SAS. Remaining EUR2.1 million Vatel loan to be converted into 3.0 million Novacyt shares. HEGC loan to be satisfied with EUR6.1 million repayment.

----------

Amryt Pharma PLC - biopharmaceuticals - Lands agreement with Swixx BioPharma AG of Switzerland. Swixx to act as exclusive distributor of Amryt's Myalepta diet medication in EU territories of Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia. Swixx will also distribute in West Balkan nations of Albania, Bosnia and Herzegovina, Kosovo, Montenegro, North Macedonia and Serbia.

----------

Westminster Group PLC - security services - Concludes trial of fever screening solutions in Stockholm Arlanda airport. Fedback from trial "extremely positive".

----------

Argo Blockchain PLC - cryptocurrency mining - Mined 252 bitcoin or bitcoin equivalent in May, down 21% from 319 in April but based on exchange rate, revenue up 7.2% to GBP1.9 million from GBP1.8 million.

----------

Hertsford Capital PLC - marine technology - Pens development agreement with Minnowtech, a provider of marine imaging platforms for shrimp farmers. Will help Minnowtech commercialise their technology.

----------

Adamas Finance Asia Ltd - investor - Net asset value per share rises 6.9% to GBP0.77 in March from GBP0.72 in December. Says well-positioned despite ongoing impact of Covid-19 pandemic.

----------

Frenkel Topping Group PLC - wealth manager - Says assets under management rose by roughly 4% to GBP880 million at April 30 from GBP849 million at the end of March. Monitoring impact of Covid-19 but says trading in first five months of year positive.

----------

Gresham House Energy Storage Fund PLC - energy storage investor - Assessing options to raise debt finance to fund acquisitions of battery storage projects.

----------

Harworth Group PLC - land regeneration - Sells first parcel of land at Hugglescote Grange development in Leicestershire to housebuilder Redrow PLC. Sold 16 acres to Redrow at December 31 book value. Harworth notes Hugglescote is one of six major development sites where work has continued despite pandemic.

----------

Town Centre Securities PLC - property investor - Collects GBP5.0 million, about 75% of rent and service charges, billed since outbreak of virus began. Will continue payment of 3.25 pence per share interim dividend. Says if final dividend is paid, it will be substantially lower.

----------

Goco Group PLC - insurance comparison - Says AutoSave platform maintains over 100% annualised customer growth rate. Price comparison behaviour at insurance, financial and online services showing gradual signs of return to pre-Covid-19 levels. Reports 29% fewer energy provider switches in UK in April compared to year prior.

----------

DP Eurasia NV - Domino's Pizza brand franchisee - Continuing to operate under constraints due to Covid-19. Sales between March 16 and May 31 down 23% year-on-year, having rises 20% between January 1 and March 15. Dine-in service unavailable in some countries and take-aways reduced, especially in Russia.

----------

Empyrean Energy PLC - oil and gas explorer - Secures 12-month extension for first phase drilling at block 29/11 in China. Empyrean requested extension from China National Offshore Oil Corp due to Covid-19 lockdowns.

----------

Kavango Resources PLC - exploration - Granted two prospective licences in Botswana section of Kalahari copper belt. Licence has initial three-year terms but can be extended to maximum of seven years. Notes Covid-19 lockdowns in Botswana beginning to ease.

----------

BlueRock Diamonds PLC - diamond production - Says no Covid-19 cases at Kareevlei diamond mine in South Africa. Output averaging 2,000 tonnes a day since May 11, 65% higher than daily output in fourth quarter of 2019.

----------

Taseko Mines Ltd - copper miner - Says no operational disruption of known cases of Covid-19 at Taseko's mines. Leaves 2020 output guidance unchanged abut adds cost-cutting measures across supply chain continue.

----------

United Oil & Gas PLC - oil & gas - Encounters over 120 metre net pay across four hydrocarbon-bearing intervals at El Salmiyah-5 well on Abu Sennan concession in Egypt - main target potentially materially larger than previously believed. Flow rates of 4,100 barrels of oil per day achieved from Kharita Reservoir during well-testing. Net production from the Abu Sennan asset as a whole likely to rise to over 2,500 barrels of oil equivalent per day in the coming weeks.

----------

Cadence Minerals PLC - lithium mining - Joint venture partner Hastings Technology Metals enters into binding master agreement with the German automotive supplier Schaeffler Technologies for the targeted supply of its MREC, the product mined and processed from Yangibana project in the Gascoyne region, Western Australia. Cadence owns 30% of the Yangibana, Yangibana North, Gossan, Hook, Kanes Gossan and Lions Ear rare earth deposit, which form part of the Yangibana rare earth deposit.

----------

Beowulf Mining PLC - mineral exploration- Chief Executive Kurt Budge writes to Ibrahim Baylan, minister for Business, Industry and Innovation, the government of Sweden. "Beowulf has several thousand Swedish shareholders, who own over 67 per cent of the company. They have witnessed the government's unacceptable mishandling of the Kallak application and false promises; the opportunity cost of which is incalculable. They are demanding the government be fully transparent now and remove all uncertainty as to when a decision on Kallak will be taken," Budge wrote.

----------

Red Rock Resources PLC - gold and manganese - Joint venture Red Rock Australasia Pty Ltd applies for four additional gold exploration licence areas totalling 916 square kilometre in the Central Victoria Goldfields region of Australia. Applications double the landholding position of Red Rock Australasia to 1,835 square kilometre and will make it one of the largest tenement holders in the Goldfields region. Joint venture partner Power Metal Resources PLC notes licence application.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Jan 2022 14:39

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

Read more
22 Nov 2021 11:37

Amryt to delist from AIM, concentrate on Nasdaq trading

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced its intention to cancel its shares from trading on AIM on Monday, with effect on 11 January.

Read more
9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Read more
19 Oct 2021 15:54

Amryt Pharma granted another two US patents

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma updated the market on patents for its lead development candidate 'Oleogel-S10' on Tuesday, as well as its recently-acquired and third commercial product 'Mycapssa'.

Read more
14 Sep 2021 07:32

IN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisition

IN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisition

Read more
6 Aug 2021 14:41

IN BRIEF: Amryt hikes guidance on record second quarter results

IN BRIEF: Amryt hikes guidance on record second quarter results

Read more
6 Aug 2021 12:02

Record second quarter sees Amryt lift guidance further

(Sharecast News) - Amryt Pharma reported record second quarter results on Friday, raising its full-year guidance, as revenue in the three months ended 30 June came in at $62.8m, up from $46.2m year-on-year.

Read more
29 Jul 2021 17:10

EXECUTIVE CHANGES: HL CFO to depart; Novacyt hires CEO from Amryt

EXECUTIVE CHANGES: HL CFO to depart; Novacyt hires CEO from Amryt

Read more
17 Jun 2021 14:34

Cathal Friel-led Poolbeg Pharma set to float on AIM

(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising the funds needed to develop its product pipeline.

Read more
3 Jun 2021 19:20

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

Read more
3 Jun 2021 11:26

FDA grants Amryt's Oleogel-S10 priority review status

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced on Thursday that the United States Food and Drug Administration (FDA) has granted priority review status for the new drug application for 'Oleogel-S10', for the treatment of epidermolysis bullosa (EB).

Read more
2 Jun 2021 19:10

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
6 Apr 2021 14:54

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

Read more
31 Mar 2021 11:50

Amryt completes rolling FDA submission for Oleogel-S10

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has completed the rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for 'Oleogel-S10', it announced on Wednesday, for the potential treatment of cutaneous manifestations of junctional and dystrophic epidermolysis bullosa (EB).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.